share_log

Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market

Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market

Agile Therapeutics收到一封信,通知該公司已獲准在2024年2月16日之前恢復遵守繼續在納斯達克資本市場上市的最低股東權益要求
Benzinga ·  2023/12/06 08:08

Agile Therapeutics Received A Letter Notifying The Company That It Had Been Granted Until Feb. 16, 2024, To Regain Compliance With The Minimum Stockholders' Equity Requirement For Continued Listing On The Nasdaq Capital Market

Agile Therapeutics收到一封信,通知該公司已獲准在2024年2月16日之前恢復遵守繼續在納斯達克資本市場上市的最低股東權益要求

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論